Raymond James analyst Elliot Wilbur maintained a Buy rating on Antares Pharma (ATRS – Research Report) today. The company’s shares
Category: Healthcare
Raymond James Reaffirms Their Hold Rating on Endo International (ENDP)
Raymond James analyst Elliot Wilbur maintained a Hold rating on Endo International (ENDP – Research Report) today. The company’s shares
Teva Pharmaceutical Industries (TEVA) Receives a Buy from Raymond James
In a report released today, Elliot Wilbur from Raymond James maintained a Buy rating on Teva Pharmaceutical Industries (TEVA –
Raymond James Remains a Hold on Aerie Pharma (AERI)
In a report released today, Elliot Wilbur from Raymond James maintained a Hold rating on Aerie Pharma (AERI – Research
Bluebird Bio (BLUE) Received its Third Buy in a Row
After Oppenheimer and Canaccord Genuity gave Bluebird Bio (NASDAQ: BLUE) a Buy rating last month, the company received another Buy,
Calliditas Therapeutics (CALT) Receives a Buy from LifeSci Capital
LifeSci Capital analyst Rami Katkhuda reiterated a Buy rating on Calliditas Therapeutics (CALT – Research Report) today and set a
Agios Pharma (AGIO) Gets a Buy Rating from Needham
In a report released today, Chad Messer from Needham maintained a Buy rating on Agios Pharma (AGIO – Research Report),